Abeona Therapeutics Announces Successful Type B Meeting with U.S. FDA for ABO-102 AAV-based Gene Therapy in Sanfilippo Syndrome Type A (MPS IIIA)
July 28, 2021 07:30 ET
|
Abeona Therapeutics Inc.
Transpher A; pivotal study for intended registration of ABO-102 for MPS IIIA disease Alignment with FDA on primary study endpoint NEW YORK and CLEVELAND, July 28, 2021 (GLOBE NEWSWIRE) -- Abeona...
Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis
July 28, 2021 07:30 ET
|
Avicanna Inc.
This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. The new decree by the Colombian...
Stock Yards Bancorp Reports Second Quarter Earnings
July 28, 2021 07:30 ET
|
Stock Yards Bancorp, Inc.
LOUISVILLE, Ky., July 28, 2021 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, Central and Eastern...
Probe Metals Announces Option Payment for the La Peltrie Property, Detour Project
July 28, 2021 07:30 ET
|
Probe Metals Inc.
TORONTO, July 28, 2021 (GLOBE NEWSWIRE) -- Probe Metals Inc. (TSX-V: PRB) (“Probe” or the "Company") is pleased to announce that it has completed the second payment (the “Second Payment”) due in...
Guskin Gold Corp. (GKIN) Files OTC Markets Application to List on the OTCQB®
July 28, 2021 07:30 ET
|
Guskin Gold Corp
SAN JOSE, CA, July 28, 2021 (GLOBE NEWSWIRE) -- Guskin Gold Corp. (the “Company” or “Guskin Gold”) (OTC: GKIN), a company focused on acquiring and advancing gold properties in the world’s seventh...
Monro, Inc. Announces First Quarter Fiscal 2022 Financial Results
July 28, 2021 07:30 ET
|
Monro, Inc.
~ First Quarter Sales Up 38.4% to a Record $341.8 Million ~~ First Quarter Comparable Store Sales Increase 34.5% ~~ First Quarter Diluted EPS of $.46 and Adjusted Diluted EPS of $.55 ~~ Released...
Mydecine to Participate in Upcoming Investor Events in August 2021
July 28, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, July 28, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to...
Otonomy to Report Second Quarter 2021 Financial Results and Provide Corporate Update
July 28, 2021 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
Midland and Probe Begin Geophysical (IP) Surveys on the La Peltrie Gold Project Prior to Drilling
July 28, 2021 07:30 ET
|
Midland Exploration Inc.
MONTREAL, July 28, 2021 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD), in partnership with Probe Metals Inc. (“Probe”), is pleased to announce the start of an important...
Media Central Corporation Announces Formation of Advisory Board and Appoints Inaugural Member
July 28, 2021 07:30 ET
|
Media Central Corporation Inc.
TORONTO, July 28, 2021 (GLOBE NEWSWIRE) -- Media Central Corporation Inc. (CSE: FLYY, FSE: 3AT) ("Media Central" or the "Company"), a publicly held holding company of media assets that trades on the...
- September 26, 2024 16:58 ET MSTX, The First Leveraged MicroStrategy ETF in the U.S. Surpasses $300 Million
- September 26, 2024 16:22 ET STMicroelectronics N.V. October 22, 2024 Lead Plaintiff Deadline – STM Stockholders Should Contact Robbins LLP for Information